Colin Coffua has been named vice president, Strategic Accounts at Cryoport and John Phillips was named executive director, Consulting Services.
 
Mr. Coffua has 37 years of experience in pharmaceutical related sales and marketing. He will drive sales efforts for Cryoport’s key strategic account initiatives including key biopharma companies and CROs. Mr. Coffua joins the company from inVentiv Health, Inc. where he served as senior vice president, Strategic Accounts in the Clinical Division for the past eight years. In this position, he was responsible for the development and execution of inVentiv Health’s global clinical development sales and strategy, and executive relationships for pharmaceutical clients.
 
Jerrell Shelton, chief executive officer of Cryoport, said, “We are pleased to welcome Colin to our Cryoport team where he will focus on growing revenue by winning larger, strategic accounts, predominantly in biopharma and clinical research organizations. Colin is a highly effective manager with a demonstrable track record in building and maintaining business relationships with some of the world’s largest biopharma companies. His strong industry network will be of great assistance as he spearheads our efforts to further penetrated the life sciences industry with our advanced cold chain logistics solutions.”
 
Mr. Phillips will work to establish Cryoport’s Temperature Controlled Logistics Consulting Division, assisting life sciences partners in devising and implementing strategies for global logistics tailored to their individual needs. Mr. Phillips has more than 30 years of experience in sales and development of technology services, with his primary expertise in the consulting and outsourcing services marketplace. Prior to joining the company, Mr. Phillips was with Windstream Communications, where he was responsible for the leadership, strategic direction and management of Windstream’s Enterprise Managed Services.

Mr. Shelton said, “Since its launch in 2016, our Temperature Controlled Logistics Consulting Service has provided much-needed logistics planning services to life sciences companies as they developed clinical-stage therapies. As our clients move closer to commercializing their regenerative therapies and face increasingly complex logistics requirements, the need for strategic planning in logistics management has become even more evident. John brings an acute understanding of managed services business and an expansive knowledge of services led selling. We are looking forward to John’s contributions as he supports Cryoport’s clients through our consulting business.”